Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2010-11-25

Original market date: See footnote 1

2004-12-07

Product name:

PHL-SODIUM POLYSTYRENE SULFONATE RETENTION ENEMA

DIN:

02261669 Electronic product monograph is not available

Company:

PHARMEL INC
6111, Avenue Royalmount, Suite 100
Montreal
Quebec
Canada H4P 2T4

Class:

Human

Dosage form(s):

Suspension

Route(s) of administration:

Rectal

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

40:18.18 

Anatomical Therapeutic Chemical (ATC): See footnote 4

V03AE01 POLYSTYRENE SULPHONATE

Active ingredient group (AIG) number:See footnote5

0108701001

List of active ingredient(s)
Active ingredient(s) Strength
SODIUM POLYSTYRENE SULFONATE 250 MG / ML
Version 4.0.2
Date modified: